VP Early Stage Clinical Development
Agenus Inc.
Lexington, Massachusetts, United States
With a profound dedication for helping those affected by cancer, Dr. Joseph Grossman brings extensive oncology expertise, specializing in gastrointestinal disease. He serves as the vice president, early clinical development at Agenus, where he spearheads their clinical-stage immunotherapy pipeline. Joe plays a pivotal role in the company’s ongoing colorectal cancer program. Previously, he was an instructor in medicine, hematology and oncology, at Harvard Medical School. He also held prominent roles at Beth Israel Deaconess Medical Center, serving as a physician in GI Oncology and a director of the molecular tumor board. Joe earned his MD from Brown University
Disclosure information not submitted.
